Skip to Content

Label Changes for:

Viracept (nelfinavir mesylate) Tablets and Oral Powder

November 2008

Changes have been made to the PATIENT PACKAGE INSERT sections of the safety label.

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.

Summary View


Sections Modified


Who should not take Viracept? Talk with your healthcare provider if you have liver or kidney disease. ...Viracept can be used in patients with mild liver disease without any dose adjustment. Viracept should not be used in patients with either moderate or severe liver disease. Medicines you should not take with Viracept: Crestor(rosuvastatin) [added] Medicines that require dose adjustments: Before you take PDE5 Inhibitors, such as Viagra (sildenafil), Levitra (vardenafil) or Cialis (tadalafil) with Viracept, talk to your healthcare provider about possible drug interactions and side effects. If you take these types of drugs and Viracept together, you may be at an increased risk of side effects of these drugs...

Nov 2008 Label & PPI not available on this site.